FUJIFILM Diosynth Appoints Head of NC Ops

FUJIFILM Diosynth Biotechnologies (FDB) has appointed Christine Vannais as chief operating officer of its North Carolina site, effective April 1, 2020. In this role, Ms. Vannais will lead all aspects of FDB’s North Carolina Operations.
 
Ms. Vannais joined the company in 2012 and has led the North Carolina Manufacturing Operations team since 2014 as part of the Site Leadership Team. In this role she has been responsible for the site’s 24/7 manufacturing operations, which include cGMP production in both microbial and mammalian systems.
 
“I am delighted to have Christine as lead of our North Carolina site,” said Martin Meeson, currently President & COO of the North Carolina site. “She brings a wealth of experience and demonstrated leadership. Christine will be a key contributor in our continued growth, aligned with our mission to be Partners for Life, advancing tomorrow’s medicines.” Martin is to be appointed President & CEO of FDB as of April 1.
 
She brings more than 20 years of experience working in a variety of industries including contract biopharmaceutical development and manufacturing, USDA biological vaccine manufacturing and research, FDA and EU small molecule manufacturing, primary and secondary packaging operations, API potent compound manufacturing, Department of Defense sites, among others.